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             In  Response                     
      Dear  Sir: 
  We thank Van den Ende and others for their comment on 
our study, in which we assessed the utility of malaria RDTs 
in our specific population of HIV-positive adults with a low 
malaria prevalence which we attributed to cotrimoxazole pro-
phylaxis and use of insecticide-treated bed nets. We concluded 
that “in similar populations of febrile outpatient HIV-positive 
adults, a negative Binax-M test can be useful for ‘ruling out’ 
malaria at the point of care.” 
  We agree with the authors of the letter that our findings do 
not apply to other settings or populations in which malaria 
prevalence is likely to be higher. Van den Ende and others 
suggest that the “diagnostic gain offered by the RDT” is low. 
However, in our setting, in the absence of an alternative test, 
presumptive treatment would generally be given to all sus-
pected cases resulting in unnecessary malaria treatment and 
missed opportunities to detect and treat the actual cause of 
the febrile illness. 
  Although it is true that malaria is a life-threatening disease 
(especially in children), malaria is also an over-diagnosed and 
over-treated condition in resource-poor settings, especially 
within low-risk patient populations, such as ours. By the same 
token, fever in an HIV-infected person is life-threatening and 
complex to manage. Malaria RDTs have the potential to help 
rule out malaria in low-risk patients, facilitating empiric treat-
ment and further diagnostic tests for the true cause of febrile 
illness. 
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